TD Waterhouse Canada’s Fennec Pharmaceuticals FENC Stock Holding History

TD Waterhouse Canada’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300	Hold	29	–	–	﹤0.01%	2274
2026 Q1	$173	Hold	29	–	–	﹤0.01%	2193
2025 Q4	$223	Hold	29	–	–	﹤0.01%	1936
2025 Q3	$231	Buy	29 +11	+61%	+$95	﹤0.01%	1961
2025 Q2	$149	Buy	+18	New	+$123	﹤0.01%	1896
2022 Q1	–	Sell	-555	Closed	-$2.5K	–	1807
2021 Q4	$2.5K	Buy	+555	New	+$4.13K	﹤0.01%	1560

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TD Waterhouse Canada's FENC Position: Q2 2026 in Review

TD Waterhouse Canada held its Fennec Pharmaceuticals (FENC) position steady in Q2 2026 at 29 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

TD Waterhouse Canada first reported a position in FENC in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.5K in Q4 2021. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

TD Waterhouse Canada held 29 shares of Fennec Pharmaceuticals worth $300 as of Q2 2026.
TD Waterhouse Canada left its Fennec Pharmaceuticals share count unchanged in Q2 2026.
Fennec Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2274 holding.
TD Waterhouse Canada first reported a position in Fennec Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
TD Waterhouse Canada's Fennec Pharmaceuticals position peaked at $2.5K in Q4 2021.
105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.